Selected research
Industry Growth & Trends
Global Esomeprazole Capsule Industry Growth and Trends Forecast to 2032
Market perspective
The global Esomeprazole Capsule market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Esomeprazole Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Esomeprazole Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Esomeprazole Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Esomeprazole Capsule include Teva., Sandoz, Sanofi, Novartis, Mylan, Stada, Saval Pharmaceutical, Mepha and KernPharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Esomeprazole Capsule market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Esomeprazole Capsule market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Esomeprazole Capsule market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Esomeprazole Capsule.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Esomeprazole Capsule market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Esomeprazole Capsule Market by Company
Teva.
Sandoz
Sanofi
Novartis
Mylan
Stada
Saval Pharmaceutical
Mepha
KernPharm
Garmish Pharmaceuticals
CQ Lummy
Blaskov
AstraZeneca AB
Actavis
Esomeprazole Capsule Segment by Type
Short-Term Use
Long-Term Use
Esomeprazole Capsule Segment by Application
Duodenal Ulcers
Gastroesophageal Reflux Disease
Others
Esomeprazole Capsule Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esomeprazole Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Esomeprazole Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esomeprazole Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Esomeprazole Capsule manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Esomeprazole Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Short-Term Use
- Long-Term Use
Applications
- Duodenal Ulcers
- Gastroesophageal Reflux Disease
- Others
Companies covered
- Teva.
- Sandoz
- Sanofi
- Novartis
- Mylan
- Stada
- Saval Pharmaceutical
- Mepha
- KernPharm
- Garmish Pharmaceuticals
- CQ Lummy
- Blaskov
- AstraZeneca AB
- Actavis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Esomeprazole Capsule Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Esomeprazole Capsule Sales Estimates and Forecasts (2021-2032)
- 1.3 Esomeprazole Capsule Market by Type
- 1.3.1 Short-Term Use
- 1.3.2 Long-Term Use
- 1.4 Global Esomeprazole Capsule Market Size by Type
- 1.4.1 Global Esomeprazole Capsule Market Size Overview by Type (2021-2032)
- 1.4.2 Global Esomeprazole Capsule Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Esomeprazole Capsule Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Esomeprazole Capsule Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Esomeprazole Capsule Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Esomeprazole Capsule Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Esomeprazole Capsule Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Esomeprazole Capsule Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Esomeprazole Capsule Industry Trends
- 2.2 Esomeprazole Capsule Industry Drivers
- 2.3 Esomeprazole Capsule Industry Opportunities and Challenges
- 2.4 Esomeprazole Capsule Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Esomeprazole Capsule Revenue (2021-2026)
- 3.2 Global Top Players by Esomeprazole Capsule Sales (2021-2026)
- 3.3 Global Top Players by Esomeprazole Capsule Price (2021-2026)
- 3.4 Global Esomeprazole Capsule Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Esomeprazole Capsule Major Company Production Sites & Headquarters
- 3.6 Global Esomeprazole Capsule Company, Product Type & Application
- 3.7 Global Esomeprazole Capsule Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Esomeprazole Capsule Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Esomeprazole Capsule Players Market Share by Revenue in 2025
- 3.8.3 2025 Esomeprazole Capsule Tier 1, Tier 2, and Tier 3
4 Esomeprazole Capsule Regional Status and Outlook
- 4.1 Global Esomeprazole Capsule Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Esomeprazole Capsule Historic Market Size by Region
- 4.2.1 Global Esomeprazole Capsule Sales in Volume by Region (2021-2026)
- 4.2.2 Global Esomeprazole Capsule Sales in Value by Region (2021-2026)
- 4.2.3 Global Esomeprazole Capsule Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Esomeprazole Capsule Forecasted Market Size by Region
- 4.3.1 Global Esomeprazole Capsule Sales in Volume by Region (2027-2032)
- 4.3.2 Global Esomeprazole Capsule Sales in Value by Region (2027-2032)
- 4.3.3 Global Esomeprazole Capsule Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Esomeprazole Capsule by Application
- 5.1 Esomeprazole Capsule Market by Application
- 5.1.1 Duodenal Ulcers
- 5.1.2 Gastroesophageal Reflux Disease
- 5.1.3 Others
- 5.2 Global Esomeprazole Capsule Market Size by Application
- 5.2.1 Global Esomeprazole Capsule Market Size Overview by Application (2021-2032)
- 5.2.2 Global Esomeprazole Capsule Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Esomeprazole Capsule Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Esomeprazole Capsule Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Esomeprazole Capsule Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Esomeprazole Capsule Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Esomeprazole Capsule Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Esomeprazole Capsule Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva.
- 6.1.1 Teva. Company Information
- 6.1.2 Teva. Business Overview
- 6.1.3 Teva. Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva. Esomeprazole Capsule Product Portfolio
- 6.1.5 Teva. Recent Developments
- 6.2 Sandoz
- 6.2.1 Sandoz Company Information
- 6.2.2 Sandoz Business Overview
- 6.2.3 Sandoz Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sandoz Esomeprazole Capsule Product Portfolio
- 6.2.5 Sandoz Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sanofi Esomeprazole Capsule Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 Novartis
- 6.4.1 Novartis Company Information
- 6.4.2 Novartis Business Overview
- 6.4.3 Novartis Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Novartis Esomeprazole Capsule Product Portfolio
- 6.4.5 Novartis Recent Developments
- 6.5 Mylan
- 6.5.1 Mylan Company Information
- 6.5.2 Mylan Business Overview
- 6.5.3 Mylan Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Mylan Esomeprazole Capsule Product Portfolio
- 6.5.5 Mylan Recent Developments
- 6.6 Stada
- 6.6.1 Stada Company Information
- 6.6.2 Stada Business Overview
- 6.6.3 Stada Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Stada Esomeprazole Capsule Product Portfolio
- 6.6.5 Stada Recent Developments
- 6.7 Saval Pharmaceutical
- 6.7.1 Saval Pharmaceutical Company Information
- 6.7.2 Saval Pharmaceutical Business Overview
- 6.7.3 Saval Pharmaceutical Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Saval Pharmaceutical Esomeprazole Capsule Product Portfolio
- 6.7.5 Saval Pharmaceutical Recent Developments
- 6.8 Mepha
- 6.8.1 Mepha Company Information
- 6.8.2 Mepha Business Overview
- 6.8.3 Mepha Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Mepha Esomeprazole Capsule Product Portfolio
- 6.8.5 Mepha Recent Developments
- 6.9 KernPharm
- 6.9.1 KernPharm Company Information
- 6.9.2 KernPharm Business Overview
- 6.9.3 KernPharm Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 KernPharm Esomeprazole Capsule Product Portfolio
- 6.9.5 KernPharm Recent Developments
- 6.10 Garmish Pharmaceuticals
- 6.10.1 Garmish Pharmaceuticals Company Information
- 6.10.2 Garmish Pharmaceuticals Business Overview
- 6.10.3 Garmish Pharmaceuticals Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Garmish Pharmaceuticals Esomeprazole Capsule Product Portfolio
- 6.10.5 Garmish Pharmaceuticals Recent Developments
- 6.11 CQ Lummy
- 6.11.1 CQ Lummy Company Information
- 6.11.2 CQ Lummy Business Overview
- 6.11.3 CQ Lummy Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 CQ Lummy Esomeprazole Capsule Product Portfolio
- 6.11.5 CQ Lummy Recent Developments
- 6.12 Blaskov
- 6.12.1 Blaskov Company Information
- 6.12.2 Blaskov Business Overview
- 6.12.3 Blaskov Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Blaskov Esomeprazole Capsule Product Portfolio
- 6.12.5 Blaskov Recent Developments
- 6.13 AstraZeneca AB
- 6.13.1 AstraZeneca AB Company Information
- 6.13.2 AstraZeneca AB Business Overview
- 6.13.3 AstraZeneca AB Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 AstraZeneca AB Esomeprazole Capsule Product Portfolio
- 6.13.5 AstraZeneca AB Recent Developments
- 6.14 Actavis
- 6.14.1 Actavis Company Information
- 6.14.2 Actavis Business Overview
- 6.14.3 Actavis Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Actavis Esomeprazole Capsule Product Portfolio
- 6.14.5 Actavis Recent Developments
7 North America by Country
- 7.1 North America Esomeprazole Capsule Sales by Country
- 7.1.1 North America Esomeprazole Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Esomeprazole Capsule Sales by Country (2021-2026)
- 7.1.3 North America Esomeprazole Capsule Sales Forecast by Country (2027-2032)
- 7.2 North America Esomeprazole Capsule Market Size by Country
- 7.2.1 North America Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Esomeprazole Capsule Market Size by Country (2021-2026)
- 7.2.3 North America Esomeprazole Capsule Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Esomeprazole Capsule Sales by Country
- 8.1.1 Europe Esomeprazole Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Esomeprazole Capsule Sales by Country (2021-2026)
- 8.1.3 Europe Esomeprazole Capsule Sales Forecast by Country (2027-2032)
- 8.2 Europe Esomeprazole Capsule Market Size by Country
- 8.2.1 Europe Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Esomeprazole Capsule Market Size by Country (2021-2026)
- 8.2.3 Europe Esomeprazole Capsule Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Esomeprazole Capsule Sales by Country
- 9.1.1 Asia-Pacific Esomeprazole Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Esomeprazole Capsule Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Esomeprazole Capsule Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Esomeprazole Capsule Market Size by Country
- 9.2.1 Asia-Pacific Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Esomeprazole Capsule Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Esomeprazole Capsule Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Esomeprazole Capsule Sales by Country
- 10.1.1 South America Esomeprazole Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Esomeprazole Capsule Sales by Country (2021-2026)
- 10.1.3 South America Esomeprazole Capsule Sales Forecast by Country (2027-2032)
- 10.2 South America Esomeprazole Capsule Market Size by Country
- 10.2.1 South America Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Esomeprazole Capsule Market Size by Country (2021-2026)
- 10.2.3 South America Esomeprazole Capsule Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Esomeprazole Capsule Sales by Country
- 11.1.1 Middle East and Africa Esomeprazole Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Esomeprazole Capsule Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Esomeprazole Capsule Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Esomeprazole Capsule Market Size by Country
- 11.2.1 Middle East and Africa Esomeprazole Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Esomeprazole Capsule Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Esomeprazole Capsule Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Esomeprazole Capsule Value Chain Analysis
- 12.1.1 Esomeprazole Capsule Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Esomeprazole Capsule Production Mode & Process
- 12.2 Esomeprazole Capsule Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Esomeprazole Capsule Distributors
- 12.2.3 Esomeprazole Capsule Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst